Samrat Pharmachem Limited (530125) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Samrat Pharmachem Limited stock ₹396, price ₹235, upside +68.4%, quality 50 out of 100. Rating: strongly undervalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Samrat Pharmachem Limited
530125 · BSECheap (41% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range ₹182.83 – ₹1,193 · fair‑value band ₹238.36 – ₹651.32 · the ₹235.05 price screens below the ₹395.84 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Samrat Pharmachem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Samrat Pharmachem Limited manufactures and sells pharmaceutical chemicals in India. It offers iodine salts and bromines salts, as well as iodine derivatives for industries, such as pharmaceuticals, chemicals, food, fertilizers, salt, etc. The company also exports its products worldwide.
Show moreShow less
Samrat Pharmachem Limited was founded in 1992 and is based in Mumbai, India.
Stock analysis
Samrat Pharmachem Limited (530125) currently trades at ₹235.05, while our model-based Fair Value estimate is ₹395.84, implying the stock looks roughly 41% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹387.23 per share, and 5 of the 7 models we run sit above the ₹235.05 price.
Bear case: the Asset-Based group reads lowest at ₹153.90, and 2 of the 7 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹238.36 (bear) to ₹651.32 (bull), the price of ₹235.05 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Samrat Pharmachem Limited reported revenue of ₹2.9B in FY2026 versus ₹2.2B in FY2022, a compound +6.9%/yr. Reported net income was −₹33.1M in FY2026.
Key figures
Market cap ₹355M (≈ $3.8M) Micro · P/E ratio 7.0 · P/S ratio 0.16 · EPS (TTM) ₹10.24 · Dividend yield 0.9% · Net margin 2.3% · Return on assets (EBIT) 11.0% (5-year average) · Operating margin 4.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).
What moves the price
The share trades about 18% below its 52-week high and 21% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Materials peers we cover trades at −44% fair-value upside, at 68%, 530125 screens cheaper than that median.
Fair Value models
All 7 models by family
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 530125, get fair value alerts →
Compare Samrat Pharmachem Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 757 stocks
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Materials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Wanhua Chemical Group 600309 | ¥69.18 | ¥68.03 | −2% | vs 530125 |
| Linde plc LIN | $515.11 | $446.62 | −13% | vs 530125 |
| PPG Industries, Inc PPG | $120.82 | $77.68 | −36% | vs 530125 |
| DSM-Firmenich AG DSFIR | CHF 96.00 | CHF 58.32 | −39% | vs 530125 |
| Asian Paints Limited ASIANPAINT | ₹2,625 | ₹1,479 | −44% | vs 530125 |
| The Sherwin-Williams Company SHW | $344.15 | $152.59 | −56% | vs 530125 |
| Givaudan SA GIVN | CHF 4,072 | CHF 1,618 | −60% | vs 530125 |
| EMS-CHEMIE HOLDING AG EMSN | CHF 836.00 | CHF 284.63 | −66% | vs 530125 |
| Ecolab Inc ECL | $302.59 | $97.18 | −68% | vs 530125 |
| Air Products and Chemicals, Inc APD | $306.92 | $75.33 | −75% | vs 530125 |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Samrat Pharmachem Limited (530125) overvalued or undervalued?
What is the fair value of 530125?
What is the quality score of 530125?
What is the price target for Samrat Pharmachem Limited (530125)?
What is the Samrat Pharmachem Limited stock forecast for 2026?
What is the revenue of Samrat Pharmachem Limited (530125)?
Does Samrat Pharmachem Limited pay a dividend?
How much is the dividend of Samrat Pharmachem Limited (530125)?
What growth is priced into Samrat Pharmachem Limited (530125)?
What discount rate (WACC) does the fair value of 530125 use?
What is a reverse DCF?
How much growth has Samrat Pharmachem Limited (530125) delivered so far?
How fast is the sector of Samrat Pharmachem Limited (530125) growing?
What is the free cash flow yield of Samrat Pharmachem Limited (530125)?
What is the intrinsic value of Samrat Pharmachem Limited (530125)?
Is Samrat Pharmachem Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 530125?
How much is Samrat Pharmachem Limited worth?
What do the bullish and bearish scenarios say about 530125?
What is the P/E ratio of 530125?
How far is 530125 from its 52-week high?
Which stocks are comparable to Samrat Pharmachem Limited?
Is Samrat Pharmachem Limited stock attractive at the current price?
How is the fair value of 530125 calculated?
Is it still worth investing in stocks now?
What is the share price of Samrat Pharmachem Limited (530125)?
What should I pay attention to with Samrat Pharmachem Limited right now?
Key figures of Samrat Pharmachem Limited
How large is the market capitalisation of Samrat Pharmachem Limited (530125)?
What is the P/S ratio of Samrat Pharmachem Limited (530125)?
What are the earnings per share of Samrat Pharmachem Limited (530125)?
What is the dividend yield of Samrat Pharmachem Limited (530125)?
What is the net margin of Samrat Pharmachem Limited (530125)?
What is the EBIT return on assets of Samrat Pharmachem Limited (530125)?
What is the operating margin of Samrat Pharmachem Limited (530125)?
How fast is revenue growing at Samrat Pharmachem Limited (530125)?
How fast are earnings growing at Samrat Pharmachem Limited (530125)?
How much net debt does Samrat Pharmachem Limited (530125) carry?
Watch Samrat Pharmachem Limited in the live analysis
One click puts Samrat Pharmachem Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.